HUGE

FSD Pharma Inc. Class B · NASDAQ

Sector Health Technology
Industry Biotechnology
Website fsdpharma.com
Employees(FY) 17
ISIN CA35954B4047

Performance

-14.53%

1W

-44.67%

1M

-58.29%

3M

-66.07%

6M

-62.13%

YTD

-71.3%

1Y

Profile

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

Advanced Technical Analysis

Technical Analysis of HUGE 2024-05-03

Overview:

In analyzing the technical indicators for the stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day Moving Average (MA) has been consistently decreasi...

See more ...

Recent News & Updates

2024-05-06 20:30
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia(Accesswire)
2024-04-29 20:33
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication(Accesswire)
2024-04-24 19:47
FSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd(TM)(Accesswire)
2024-04-21 20:00
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)(Accesswire)
2024-04-16 20:00
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products(Accesswire)
2024-04-14 20:00
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption(Accesswire)
2024-04-07 10:55
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency(Newsfilecorp)
2024-04-01 10:00
FSD Pharma Announces Filing of Year-End 2023 Results(Accesswire)
2024-03-26 20:00
FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults(Accesswire)
2024-03-10 20:00
FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)(Accesswire)
2024-03-04 19:00
FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum(Accesswire)
2024-02-27 19:00
FSD Pharma Announces Debt Settlement(Accesswire)
2024-02-25 19:00
FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)(Accesswire)
2024-02-16 06:50
FSD Pharma Announces US ATM Offering(Accesswire)
2024-02-05 18:00
Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million(Accesswire)
2024-01-29 03:30
FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates(Accesswire)
2024-01-15 18:30
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot(Accesswire)
2024-01-11 00:10
GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case(Globenewswire)
2023-12-22 06:45
FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC(Accesswire)
2023-12-04 20:00
FSD Pharma Inc. Announces Closing of Private Placement(Accesswire)
2023-11-29 19:30
FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement(Accesswire)
2023-11-27 20:00
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness(Accesswire)
2023-11-26 18:30
FSD Pharma Inc. Obtains Final Order for Plan of Arrangement(Accesswire)
2023-11-23 18:55
Goldman Small Cap Research Publishes New Research Report on FSD Pharma, Inc.(Accesswire)
2023-11-20 20:00
FSD Pharma Inc. Securityholders Approve Plan of Arrangement with Celly Nutrition Corp.(Accesswire)
2023-11-16 19:00
FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of Arrangement(Accesswire)
2023-11-14 20:00
FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023(Accesswire)
2023-11-06 22:45
FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis(Accesswire)
2023-11-06 04:40
FSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus(Accesswire)
2023-10-22 21:00
FSD Pharma Files Management Information Circular for Proposed Arrangement with Celly Nu(Accesswire)

Page 1 of 4

previousnext